首页 | 本学科首页   官方微博 | 高级检索  
检索        

异黏蛋白与叉头框蛋白M1在肝细胞癌中的表达及其临床意义
引用本文:焦文静,张金艳,马鸣,郭秀娟,冯军花,邵俊国,焦文鹏.异黏蛋白与叉头框蛋白M1在肝细胞癌中的表达及其临床意义[J].癌变.畸变.突变,2021,33(5):349-353,359.
作者姓名:焦文静  张金艳  马鸣  郭秀娟  冯军花  邵俊国  焦文鹏
作者单位:河北医科大学第四医院检验科, 河北石家庄 050011
基金项目:河北省卫健委基金资助课题(20200110)
摘    要:目的:探讨异黏蛋白(MTDH)和叉头框蛋白M1(FoxM1)在肝细胞癌中的表达及其临床意义。方法:收集156例肝细胞癌(HCC)手术切除标本,免疫组织化学和反转录PCR (RT-PCR)分别检测MTDH、FoxM1蛋白和mRNA在HCC中的表达情况,并分析其表达与临床病理指标及预后的关系。结果:免疫组织化学结果显示,MTDH在HCC中的阳性表达率为71.2%(111/156),FoxM1在HCC中的阳性表达率为64.7%(101/156),其表达与肿瘤数目、TNM分期、微血管侵犯、卫星结节等相关(P < 0.05)。RT-PCR方法检测显示,MTDH和FoxM1在肝细胞癌中的表达较对照组明显升高(P < 0.05)。Spearman相关性分析结果显示,MTDH与FoxM1的表达存在明显的相关性(r=0.507,P < 0.01)。Kaplan-Meier生存分析结果显示肝细胞癌患者生存时间与TNM分期、微血管侵犯、卫星结节、MTDH和FoxM1有关,差异均有统计学意义(P < 0.05);多因素Cox回归分析结果显示TNM分期和MTDH的表达是影响患者生存时间的主要因素。结论:对于HCC患者,MTDH和FoxM1与诸多临床因素有关,MTDH为患者预后影响因素,且MTDH和FoxM1的表达存在相关性。

关 键 词:肝细胞癌  异黏蛋白  叉头框蛋白M1  免疫组织化学  预后  
收稿时间:2020-11-08
修稿时间:2021-04-28

Expression and clinical significance of MTDH and FoxM1 in hepatocellular carcinomas
JIAO Wenjing,ZHANG Jinyan,MA Ming,GUO Xiujuan,FENG Junhua,SHAO Junguo,JIAO Wenpeng.Expression and clinical significance of MTDH and FoxM1 in hepatocellular carcinomas[J].Carcinogenesis,Teratogenesis and Mutagenesis,2021,33(5):349-353,359.
Authors:JIAO Wenjing  ZHANG Jinyan  MA Ming  GUO Xiujuan  FENG Junhua  SHAO Junguo  JIAO Wenpeng
Institution:Laboratory Department of the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, Hebei, China
Abstract:OBJECTIVE: To explore relationships between expression of metadherin (MTDH) and forkhead box M1 (FoxM1) in hepatocellular carcinomas (HCC) and the clinicopathological features and prognosis of patients. METHODS: Surgical specimens from 156 HCC patients were usedof. Expressions of MTDH and FoxM1 were detected by immunohistochemistry and to analyze the relationship between the expression of MTDH and FoxM1 and the clinical pathological characteristics and prognosis. RESULTS: Immunohistochemical results showed that positive rates of MTDH was 71.2% (111/156). Expressions of MTDH were significantly related to tumor numbers,TNM stages,microvascular invasions,satellite nodules (P < 0.05). Positive rates of FoxM1 was 64.7% (101/156). Expressions of FoxM1 were significantly related to cirrhosis, tumor numbers, TNM stages, microvascular invasions, satellite nodules (P < 0.05). RT-PCR showed that expression of MTDH and FoxM1 was significantly increased. Spearman correlation analyses showed that there was a significant correlation between MTDH and FoxM1. Results from the Kaplan-Meier survival analyses showed that survival times were significantly related to TNM stages, microvascular invasions, satellite nodules, expressions of MTDH and FoxM1 (P < 0.05). Results from the multivariate Cox regression analyses showed that TNM stages and MTDH expressions were the main factors which influenced survival times of the patients. CONCLUSION: For HCC patients,MTDH and FoxM1 expressions were related to many clinical factors. Particularly,MTDH expression was a prognostic factor and there was a significant correlation between MTDH and FoxM1 expressions.
Keywords:hepatocellular carcinoma  metadherin  forkhead box M1  immunohistochemistry  prognosis  
本文献已被 万方数据 等数据库收录!
点击此处可从《癌变.畸变.突变》浏览原始摘要信息
点击此处可从《癌变.畸变.突变》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号